Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study.

Ferrero A, Ditto A, Giorda G, Gadducci A, Greggi S, Daniele A, Fuso L, Panuccio E, Scaffa C, Raspagliesi F, Sismondi P, Biglia N.

Eur J Surg Oncol. 2014 Jul;40(7):891-8. doi: 10.1016/j.ejso.2013.11.026.

PMID:
24378007
2.

Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.

Fotiou S, Aliki T, Petros Z, Ioanna S, Konstantinos V, Vasiliki M, George C.

Gynecol Oncol. 2009 Aug;114(2):178-82. doi: 10.1016/j.ygyno.2009.04.025.

PMID:
19450872
3.

Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.

Santillan A, Karam AK, Li AJ, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Bristow RE.

Gynecol Oncol. 2007 Mar;104(3):686-90.

PMID:
17141302
4.

Outcomes and patterns of secondary relapse in platinum-sensitive ovarian cancer: implications for tertiary cytoreductive surgery.

Tang J, Liu DL, Shu S, Tian WJ, Liu Y, Zang RY.

Eur J Surg Oncol. 2013 Jul;39(7):786-91. doi: 10.1016/j.ejso.2013.02.006.

PMID:
23490332
5.

[Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].

Tu H, Huang H, Huang QD, Li Z, Feng YL, Liu JH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Dec;47(12):928-33. Chinese.

PMID:
23324194
6.

The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study.

Gadducci A, Cosio S, Zola P, Sostegni B, Ferrero AM, Teti G, Cristofani R, Sartori E.

Gynecol Oncol. 2010 Mar;116(3):358-63. doi: 10.1016/j.ygyno.2009.11.008.

PMID:
19954826
7.

Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer.

Zang RY, Zhang ZY, Li ZT, Chen J, Tang MQ, Liu Q, Cai SM.

J Surg Oncol. 2000 Sep;75(1):24-30.

PMID:
11025458
8.

Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study.

Deraco M, Virzì S, Iusco DR, Puccio F, Macrì A, Famulari C, Solazzo M, Bonomi S, Grassi A, Baratti D, Kusamura S.

BJOG. 2012 Jun;119(7):800-9. doi: 10.1111/j.1471-0528.2011.03207.x.

9.

Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.

Gouy S, Goetgheluck J, Uzan C, Duclos J, Duvillard P, Morice P.

Eur J Surg Oncol. 2012 Feb;38(2):170-5. doi: 10.1016/j.ejso.2011.10.006.

PMID:
22104389
10.

Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors.

Blanchard P, Plantade A, Pagès C, Afchain P, Louvet C, Tournigand C, de Gramont A.

Gynecol Oncol. 2007 Jan;104(1):41-5.

PMID:
16952391
11.

Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes.

Uzan C, Morice P, Rey A, Pautier P, Camatte S, Lhommé C, Haie-Meder C, Duvillard P, Castaigne D.

Ann Surg Oncol. 2004 Jul;11(7):658-64.

PMID:
15197013
12.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients.

Bakrin N, Cotte E, Golfier F, Gilly FN, Freyer G, Helm W, Glehen O, Bereder JM.

Ann Surg Oncol. 2012 Dec;19(13):4052-8. doi: 10.1245/s10434-012-2510-4.

PMID:
22825772
13.

Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery.

Benedetti Panici P, Perniola G, Angioli R, Zullo MA, Manci N, Palaia I, Bellati F, Plotti F, Calcagno M, Basile S.

Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1245-51.

PMID:
17425680
14.

Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors.

Petrillo M, Fagotti A, Ferrandina G, Fanfani F, Costantini B, Vizzielli G, Pedone Anchora L, Nero C, Margariti PA, Scambia G.

Gynecol Oncol. 2013 Oct;131(1):36-41. doi: 10.1016/j.ygyno.2013.06.020.

PMID:
23791829
15.

Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes.

Skaznik-Wikiel ME, Lesnock JL, McBee WC, Beriwal S, Zorn KK, Richard SD, Krivak TC, Edwards RP.

Int J Gynecol Cancer. 2012 Feb;22(2):232-7. doi: 10.1097/IGC.0b013e318234f833.

PMID:
22080886
16.

Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.

Fagotti A, Petrillo M, Costantini B, Fanfani F, Gallotta V, Chiantera V, Turco LC, Bottoni C, Scambia G.

Gynecol Oncol. 2014 Feb;132(2):303-6. doi: 10.1016/j.ygyno.2013.12.028.

PMID:
24378877
17.

Retrospective analysis of outcomes of secondary debulking surgery for recurrent epithelial ovarian cancer with favorable prognostic factors.

Nasu K, Kai K, Hirakawa T, Nishida M, Matsumoto H, Kawano Y, Narahara H.

J Obstet Gynaecol Res. 2014 Mar;40(3):791-6. doi: 10.1111/jog.12222.

PMID:
24245582
18.

Lymph node metastasis in stage I epithelial ovarian cancer.

Suzuki M, Ohwada M, Yamada T, Kohno T, Sekiguchi I, Sato I.

Gynecol Oncol. 2000 Nov;79(2):305-8.

PMID:
11063662
19.

Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study.

Gao Y, Liu Z, Chen X, Luo W, Zhang L, Wang J.

BMC Cancer. 2011 Oct 11;11:439. doi: 10.1186/1471-2407-11-439.

20.

Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.

Gadducci A, Cosio S, Zola P, Sostegni B, Fuso L, Sartori E.

Int J Gynecol Cancer. 2013 Mar;23(3):461-8. doi: 10.1097/IGC.0b013e318286665b.

PMID:
23370604
Items per page

Supplemental Content

Support Center